Immunity, Inflammation and Disease Publishes Issue 1.1

LSJ-12-45832-WOAI-NW-Immunology-Cover-101x131pxWe are pleased to announce that Immunity, Inflammation and Disease has now launched with the publication of its inaugural issue. Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal, providing rapid publication of cutting-edge research across the broad field of immunology.

The Editor-in-Chief, Marc Veldhoen has selected these papers to highlight from the issue:

purple_lock_open Relative contribution of IL-1?, IL-1? and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG by Marie-Laure Bourigault, Noria Segueni, Stéphanie Rose, Nathalie Court, Rachel Vacher, Virginie Vasseur, François Erard, Marc Le Bert, Irene Garcia, Yoichiro Iwakura, Muazzam Jacobs, Bernhard Ryffel and Valerie F. J. Quesniaux
Summary: Here, we confirm that both TNF and IL-1 pathways are required to control M. tuberculosis infection since absence of both IL-1a and IL-1ß recapitulated the dramatic defect seen in the absence of IL-1R1 or TNF. However, presence of either IL-1a or IL-1ß allows some control of acute M. tuberculosis infection. Further, although TNF is essential for the early control of infection by either virulent or attenuated mycobacteria, IL-1 pathway is dispensable for controlling less virulent infection by M. bovis BCG.

purple_lock_open Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways by Kolandaswamy Anbazhagan, Amrathlal Rabbind Singh, Piec Isabelle, Ibata Stella, Alleaume-De Martel Céline, Eliane Bissac, Brassart Bertrand, Nyga Rémy, Taylor Naomi, Fuentes Vincent, Jacques Rochette and Kaïss Lassoued
Summary: PI3K and MAPK exerted opposing effects on the pre-BCR-induced activation of the canonical NF-?B and c-Fos/AP1 pathways. In addition, pre-BCR-induced down-regulation of Rag1, Rag2, E2A and Pax5 transcripts occurred in a PI3K-dependent manner.

sign up for etoc alerts IID

We would like to invite you to submit your immunology paper to the journal. All authors retain copyright in their articles and benefit from high visibility on Wiley Online Library. All articles are fully open access on publication.

submit to IID

Wiley Launches New Open Access Journal: Immunity, Inflammation and Disease

LSJ-12-45832-WOAI-NW-Immunology-Cover-101x131pxWe are delighted to announce the launch of a new open access, interdisciplinary journal providing rapid publication of cutting-edge research across the broad field of immunology.

Immunity, Inflammation and Disease, the latest journal to be launched from the Wiley Open Access program, is supported by a number of major societies; British Society for Immunology; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology; and the British Society for Allergy and Clinical Immunology, as well as leading journals in the field, including Allergy (Impact Factor 6.3), European Journal of Immunology (Impact Factor 5.1) and Clinical and Experimental Allergy (Impact Factor 5.0).

All articles in Immunity, Inflammation and Disease will be published open access under the Creative Commons Attribution (CC-BY) License on Wiley Online Library and deposited in PubMed Central immediately upon publication. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organization that has a Wiley Open Access Account can publish without directly paying any publication charges.

Marc Veldhoen, a group leader at the Babraham Institute in Cambridgeshire, UK, has been appointed as Editor-in-Chief for the new journal. Dr. Veldhoen studied Medical Biology at the Faculty of Medicine, Utrecht University, The Netherlands and went on to pursue his post doctorate at the National Institute for Medical Research Mill Hill, UK.

“It is my hope and goal with Immunity, Inflammation and Disease to make a contribution towards quality open access scientific publishing and to stimulate debate. Being part of Wiley means we will make full use of its experience with quality peer reviewed scientific publishing,” said Dr. Veldhoen. “My aims are to shape it into a high quality journal publishing new and original data, and to encourage the preservation of the original scientific method of open discussion and frank exchange of thoughts and ideas.”

“We are delighted to be launching this new open access journal in immunology, particularly with support of our long term publishing partners which will be invaluable in ensuring that the new journal goes from strength to strength,” said Bob Campbell, Senior Publisher, Wiley.

The journal is open to submissions now. Visit the journal’s website www.immunityinflammationdisease.com for further information and future updates.